Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypesAmparo García-López(University of Geneva), Léonardo Scapozza(University of Geneva)Nature CommunicationsMay 17, 201810.1038/s41467-018-04110-1Cited by 69SaveCiteExport RISWatch citationsRelated PapersModified, cyclic dodecapeptide analog of neuropeptide Y is the smallest full agonist at the human Y<sub>2</sub> receptor|FEBS Letters|1996|42